Platelet activation and coagulation-related protein network

The platelet activation and coagulation-related protein network is a sophisticated physiological system essential for maintaining hemostasis and preventing excessive blood loss following vascular injury (StatPearls, 2023). This network involves a coordinated interplay between the vascular endothelium, circulating platelets, and a series of plasma proteins known as coagulation factors (NIH, 2022). Upon injury, platelets adhere to exposed subendothelial collagen and von Willebrand factor, leading to their activation and the release of agonists like ADP and thromboxane A2, which recruit further platelets to form a primary hemostatic plug (PubMed, 2021). Concurrently, the coagulation cascade is initiated via the extrinsic or intrinsic pathways, converging on the activation of Factor X and the subsequent generation of thrombin (Wikipedia, 2024). Thrombin then converts soluble fibrinogen into insoluble fibrin strands, which cross-link to stabilize the platelet plug into a mature clot (UniProt, 2023). Pathological overactivation of this network is a central driver of cardiovascular diseases, including myocardial infarction, ischemic stroke, and venous thromboembolism (PubMed, 2022). Consequently, this network is the primary target for a wide array of pharmacological agents, including antiplatelet drugs (e.g., aspirin, P2Y12 inhibitors) and anticoagulants (e.g., heparin, warfarin, and direct oral anticoagulants), which modulate specific nodes to prevent or treat thrombosis (PubChem, 2023).

Other names

Hemostatic systemCoagulation cascadePlatelet signaling pathwayThrombotic pathway

Inhibition of cyclooxygenase-1, antagonism of P2Y12 receptors, inhibition of Factor Xa, direct thrombin inhibition, and antagonism of glycoprotein IIb/IIIa receptors.